Pre-clinical Biomarker Discovery

Discovery

Almac have extensive experience in biomarker discovery both through our commercial partnerships and our internal R&D.

The solutions we offer include:

  • Study design
  • Advice and Project Management on best approach
  • Full laboratory facilities including:
    • Pre-clinical cell line modelling
    • Gene expression including diagnostic proprietary discovery arrays
    • SNP and qPCR analysis, IHC
    • Data analysis for identification of relevant pathways and candidate genelist

Almac have the infrastructure and expertise to enable biomarker discovery in a range of disease areas. Our discovery can begin as early as the pre-clinical phase or can be carried out using retrospective analysis of FFPE datasets or in prospective clinical trials.

WEBINAR:

‘Developing and Applying Biomarkers in Early Phase Clinical Trials’

For further information click here to contact us.

Flash replacement image